drugset / Trial / NCT02038868

A Study to Evaluate the Efficacy and Safety of ASP4901 in Patients With Benign Prostate Hyperplasia

NCT02038868

Phase 2 Completed 320 enrolled Astellas Pharma Inc
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to compare the efficacy of ASP4901 with placebo in patients with benign prostatic hyperplasia. The safety and tolerability of ASP4901 will also be evaluated.

Timeline

Start
2013-07-22
Primary completion
2014-04-04
Completion
2014-04-04

Drugs

EvaluationDrugModalityDoseRoute
Subject ASP4901 Unknown Oral
Comparator Tamsulosin Other / unclassified Oral